MedPath

Duodenal Exclusion for the Treatment of Type 2 Diabetes

Not Applicable
Withdrawn
Conditions
Diabetes
Registration Number
NCT00534547
Lead Sponsor
Medtronic - MITG
Brief Summary

The purpose of this study is to investigate the role of an experimental surgery that may offer better short and long-term control of T2DM in select patients who have not achieved adequate blood sugar control with regular means.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Treatment success based on patients' glycemic control12 Months
Secondary Outcome Measures
NameTimeMethod
Physiologic Measurements, Comorbidity improvement, Improvement in QOL12 Months
© Copyright 2025. All Rights Reserved by MedPath